Wellesta is a Singapore-based company established in 2019 with a focus on supporting healthcare companies in South East Asia and India. Acting as a representative for entities without a presence in this region, Wellesta provides marketing and commercial support for their products. The company prides itself on a team of experienced industry professionals with in-depth knowledge of each market they serve. Their recent SDG50.00M Series B investment on 06 April 2023 saw participation from Mitsui USA and the Japan Bank for International Cooperation. Wellesta's mission is to offer a wider range of high-quality healthcare products at competitive prices, catering to a broader population base in the served countries. Their strategy revolves around becoming a leading and focused healthcare company through productive partnerships with other entities in the healthcare sector.
No recent news or press coverage available for Wellesta.